SCOTTSDALE, Ariz., Feb. 13, 2020 /PRNewswire/ — Healthcare Trust of America, Inc. (NYSE: HTA) («HTA») announced results for the quarter and year ended December 31, 2019.

Healthcare Trust of America, Inc. Logo. (PRNewsFoto/Healthcare Trust of America, Inc.) (PRNewsfoto/Healthcare Trust of America, In)

«In 2019, HTA grew its best-in-class portfolio with strategic accretive investments in key markets, while continuing to build strong tenant and health system relationships and strategic partnerships,» stated Chairman, CEO and President Scott D. Peters.  «As we continue to be the leader in the medical office building («MOB») industry, HTA will look ahead in 2020 for innovative ways to grow as a company and continue to provide attractive returns for our stockholders.»

Highlights

Fourth Quarter 2019:

  • Net income Attributable to Common Stockholders was $8.9 million, or $0.04 per diluted share, a decrease of $(0.03) per diluted share, compared to 2018.
  • Funds From Operations («FFO»), as defined by the National Association of Real Estate Investment Trusts («NAREIT»), was $87.3 million, or $0.41 per diluted share, for Q4 2019. Due to the adoption of Topic 842, certain initial direct costs are now reported in general and administrative expenses. For Q4 2018, HTA capitalized approximately $1.2 million of initial direct costs.
  • Normalized FFO was $88.9 million, or $0.42 per diluted share, for Q4 2019, an increase of $0.02, or 5.0%, per diluted share, compared to 2018.
  • Normalized Funds Available for Distribution («FAD») was $72.3 million for Q4 2019.
  • Same-Property Cash Net Operating Income («NOI») increased $2.8 million, or 2.5%, to $114.9 million, compared to Q4 2018. This included same-property rental revenue growth of 1.4%.
  • Leasing: HTA’s portfolio had a leased rate of 90.8% by gross leasable area («GLA») and an occupancy rate of 89.9% by GLA for Q4 2019. During Q4 2019, HTA executed approximately 1.0 million square feet of GLA of new and renewal leases. Re-leasing spreads increased to 3.4% and tenant retention for the Same-Property portfolio was 76% by GLA for Q4 2019.

Year Ended 2019:

  • Net Income Attributable to Common Stockholders was $30.2 million, or $0.14 per diluted share, a decrease of $(0.88) per diluted share, compared to 2018.
  • FFO, as defined by NAREIT, was $319.7 million, or $1.53 per diluted share, for 2019 and includes a $21.6 million, or $(0.10) per diluted share, loss related to the extinguishment of debt. For 2018, HTA capitalized approximately $4.9 million of initial direct costs.
  • Normalized FFO was $344.3 million, or $1.64 per diluted share, for 2019, an increase of $0.02, or 1.2%, per diluted share, compared to 2018.
  • Normalized FAD was $289.4 million for 2019.
  • Same-Property Cash NOI increased $12.1 million, or 2.7%, to $450.9 million, compared to 2018. This included same-property rental revenue growth of 2.3%.
  • Leasing: During the year ended December 31, 2019, HTA executed approximately 3.6 million square feet of GLA of new and renewal leases, or over 14.6% of the total GLA of its portfolio. Re-leasing spreads increased to 3.5% and tenant retention for the Same-Property portfolio was 83% by GLA year-to-date.

Balance Sheet and Capital Markets

  • Balance Sheet: HTA ended Q4 2019 with total liquidity of $1.2 billion, inclusive of $900.0 million available on our unsecured revolving credit facility, $306.2 million of unsettled equity sold under forward agreements, and $32.7 million of cash and cash equivalents. HTA also had total leverage of (i) 28.9%, measured as debt less cash and cash equivalents to total capitalization, and (ii) debt less cash and cash equivalents to Adjusted Earnings before Interest, Taxes, Depreciation and Amortization for real estate («Adjusted EBITDAre«) of 5.7x. Including the impact of the remaining forward equity to be settled, leverage would be 25% and 5.0x, respectively, using the definitions from above.
  • Equity: During 2019, HTA issued a total of $637.6 million in equity, comprised of approximately 21.6 million shares of common stock under its at-the-market («ATM») offering program on a forward basis at an average price of $29.59, of which, $584.9 million comprised of 19.7 million shares were issued in Q4 2019 at an average price of $29.68. During 2019, HTA received net proceeds of $323.4 million on 11.1 million shares that settled, of which net proceeds of $271.6 million for 9.3 million shares were attributable to Q4 2019 settlements. Accordingly, we have approximately 10.5 million shares expected to settle in 2020 for net proceeds of $306.2 million, subject to adjustment for costs to borrow under the terms of the applicable equity distribution agreements.
  • Debt: In 2019, Healthcare Trust of America Holdings, LP («HTALP») and HTA completed two transactions:
    • issued $900.0 million in senior, unsecured notes with a weighted average interest rate of 3.04% per annum and a weighted maturity of 9.5 years and used the net proceeds from the issuance to redeem $700.0 million worth of senior notes and to pay down the unsecured revolving credit facility. As part of these repayments, HTA incurred debt extinguishment costs of approximately $21.6 million; and
    • hedged $500 million of HTALP and HTA’s term loans at 2.44% which effectively fixed the interests rates of the entire portfolio of the Company, except for the revolving credit facility.

Noteworthy 2019 Activities

  • Investments: In the quarter, HTA closed on $330 million of investments totaling approximately 1.1 million square feet of GLA. For the year, HTA has now closed $558 million of investments totaling approximately 1.6 million square feet of GLA, with expected year-one contractual yields of approximately 6.1%, after operating synergies. These properties were approximately 93% occupied as of closing, and are located within HTA’s key markets. Over 55% of these properties are located on or adjacent to hospital campuses, and, all were acquired on a fee-simple basis.
  • Development/Redevelopment: As of December 31, 2019, HTA had the following development and redevelopment projects in place:
    • Developments: During 2019, HTA announced agreements to develop two new on-campus MOBs located in the key markets of Dallas, Texas and Bakersfield, California with anticipated costs of approximately $90 million totaling approximately 191,000 square feet of GLA. The new development projects have anticipated yields of over 6.5%. In total, HTA now has development projects of approximately $112 million totaling approximately 242,000 square feet of GLA and are expected to be more than 72% pre-leased upon completion.
    • Redevelopments: During 2019, HTA announced plans to redevelop two MOBs located in Los Angeles, California with estimated costs of approximately $20 million totaling approximately 105,000 square feet of GLA. In total, HTA’s redevelopment projects have anticipated costs of approximately $64 million, covering approximately 230,000 square feet of GLA.
  • Dividends: On February 13, 2020, HTA’s Board of Directors announced a quarterly cash dividend of $0.315 per share of common stock and per OP Unit. The quarterly dividend is to be paid on April 9, 2020 to stockholders of record of its common stock and holders of its OP Units on April 2, 2020.

Impact of Topic 842 Leases

  • The Financial Accounting Standards Board issued Topic 842, which was effective for HTA as of January 1, 2019. Topic 842 modifies the treatment of initial direct costs, which historically under Topic 840 were capitalized in accordance with certain criteria provided for in the applicable guidance. Topic 842 also eliminates the accounting recognition of expenses paid directly by tenants and moves certain bad debt costs from expense to revenue. During the quarter and year ended 2018, HTA capitalized $1.2 million and $4.9 million, respectively, of initial direct costs, certain of which, would now be expensed under Topic 842. In addition, for the quarter and year ended 2018, HTA recognized $3.4 million and $13.9 million, respectively, of tenant paid property taxes in both revenues and expenses and a nominal amount of bad debt costs recognized as expenses.

2020 Guidance

HTA expects 2020 guidance to range as follows:

Annual Expectations

Low

to

High

Net income attributable to common stockholders per share

$0.32

$0.36

Same-Property Cash NOI

2.0%

3.0%

FFO per share, as defined by NAREIT

$1.68

$1.71

Normalized FFO per share

$1.69

$1.73

The 2020 outlook guidance includes the following additional assumptions: (i) $500$600 million of investments at a 5.5% to 6.25% yield; (ii) $50 million of dispositions at a 6.0% average yield; (iii) general and administrative costs of $44$46 million, and (iv) approximately 226 million diluted, common shares outstanding.  HTA expects leverage, measured as (i) debt less cash and cash equivalents to total capitalization, and (ii) measured as debt less cash and cash equivalents to Adjusted EBITDAre to remain stable year-over-year.

HTA’s 2020 guidance is based on a number of various assumptions that are subject to change and many of which are outside the control of the Company.  Additionally, HTA’s guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any.  If actual results vary from these assumptions, HTA’s expectations may change.  There can be no assurance that HTA will achieve these results.

About Healthcare Trust of America, Inc.

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 24.8 million square feet of GLA, with $7.3 billion invested primarily in MOBs.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the S&P 500 and US REIT index.  More information about HTA can be found on the Company’s Website (www.htareit.com), Facebook, LinkedIn and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements with respect to HTA.  Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements.  These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing.  Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A – Risk Factors, in our 2019 Annual Report on Form 10-K and in our filings with the SEC.

Conference Call

HTA will host a conference call and webcast on Friday, February 14, 2020 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time) to review its financial performance and operating results for the quarter and year ended December 31, 2019.

Conference Call and Webcast Details:
Domestic Dial-In Number: (877) 507-6265
International Dial-In Number: (412) 902-6633
Canada Dial-In Number: (855) 669-9657
Webcast: www.htareit.com under the Investor Relations tab

Replay Conference Call Details:
Domestic Dial-In Number: (877) 344-7529
International Dial-In Number: (412) 317-0088
Canada Dial-In Number: (855) 669-9658
Conference ID: 10139033
Available February 14, 2020 (one hour after the end of the conference call) to March 14, 2020 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time)

Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands, except for share and per share data)

Year Ended December 31,

2019

2018

ASSETS

Real estate investments:

Land

$

584,546

$

481,871

Building and improvements

6,252,854

5,787,152

Lease intangibles

628,066

599,864

Construction in progress

28,150

4,903

7,493,616

6,873,790

Accumulated depreciation and amortization

(1,447,815)

(1,208,169)

Real estate investments, net

6,045,801

5,665,621

Investment in unconsolidated joint venture

65,888

67,172

Cash and cash equivalents

32,713

126,221

Restricted cash

4,903

7,309

Receivables and other assets, net

237,024

223,415

Right-of-use assets – operating leases, net

239,867

Other intangibles, net

12,553

98,738

Total assets

$

6,638,749

$

6,188,476

LIABILITIES AND EQUITY

Liabilities:

Debt

$

2,749,775

$

2,541,232

Accounts payable and accrued liabilities

171,698

185,073

Security deposits, prepaid rent and other liabilities

49,203

59,567

Lease liabilities – operating leases

198,650

Intangible liabilities, net

38,779

61,146

Total liabilities

3,208,105

2,847,018

Commitments and contingencies

Redeemable noncontrolling interests

6,544

Equity:

Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding

Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 216,453,312 and 205,267,349 shares issued and outstanding as of December 31, 2019 and 2018, respectively

2,165

2,053

Additional paid-in capital

4,854,042

4,525,969

Accumulated other comprehensive income

4,546

307

Cumulative dividends in excess of earnings

(1,502,744)

(1,272,305)

Total stockholders’ equity

3,358,009

3,256,024

Noncontrolling interests

72,635

78,890

Total equity

3,430,644

3,334,914

Total liabilities and equity

$

6,638,749

$

6,188,476

 

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share data)

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Revenues:

Rental income

$

176,199

$

172,204

$

691,527

$

696,030

Interest and other operating income

114

94

513

396

Total revenues

176,313

172,298

692,040

696,426

Expenses:

Rental

53,266

55,253

211,479

220,617

General and administrative

10,203

8,915

41,360

35,196

Transaction

1,492

70

2,350

1,003

Depreciation and amortization

78,654

69,566

290,384

279,630

Interest expense

24,031

24,457

96,632

101,849

Impairment

8,887

Total expenses

167,646

158,261

642,205

647,182

(Loss) gain on sale of real estate, net

(117)

(395)

(154)

165,977

Gain (loss) on extinguishment of debt, net

1,334

(21,646)

242

Income from unconsolidated joint venture

426

330

1,882

1,735

Other income

60

299

841

428

Net income

$

9,036

$

15,605

$

30,758

$

217,626

Net income attributable to noncontrolling interests

(118)

(276)

(604)

(4,163)

Net income attributable to common stockholders

$

8,918

$

15,329

$

30,154

$

213,463

Earnings per common share – basic:

Net income attributable to common stockholders

$

0.04

$

0.07

$

0.15

$

1.04

Earnings per common share – diluted:

Net income attributable to common stockholders

$

0.04

$

0.07

$

0.14

$

1.02

Weighted average common shares outstanding:

Basic

207,395

206,409

205,720

206,065

Diluted

211,472

210,338

209,605

210,061

Dividends declared per common share

$

0.315

$

0.310

$

1.250

$

1.230

 

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)

Year Ended December 31,

2019

2018

2017

Cash flows from operating activities:

Net income

$

30,758

$

217,626

$

65,577

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

280,969

271,441

239,044

Share-based compensation expense

10,127

9,755

6,870

Impairment

8,887

13,922

Income from unconsolidated joint venture

(1,882)

(1,735)

(782)

Distributions from unconsolidated joint venture

3,030

2,665

750

Loss (gain) on sale of real estate, net

154

(165,977)

(37,802)

Loss (gain) on extinguishment of debt, net

21,646

(242)

11,192

Change in fair value of derivative financial instruments

(884)

Changes in operating assets and liabilities:

Receivables and other assets, net

(12,857)

(17,558)

(33,295)

Accounts payable and accrued liabilities

(128)

9,478

37,406

Prepaid rent and other liabilities

8,577

3,056

5,545

Net cash provided by operating activities

340,394

337,396

307,543

Cash flows from investing activities:

Investments in real estate

(553,298)

(17,389)

(2,383,581)

Investment in unconsolidated joint venture

(68,839)

Development of real estate

(28,066)

(34,270)

(25,191)

Proceeds from the sale of real estate

4,880

305,135

80,640

Capital expenditures

(91,544)

(77,870)

(64,833)

Collection of real estate notes receivable

739

703

9,964

Advances on real estate notes receivable

(3,256)

Net cash (used in) provided by investing activities

(667,289)

176,309

(2,455,096)

Cash flows from financing activities:

Borrowings on unsecured revolving credit facility

610,000

145,000

570,000

Payments on unsecured revolving credit facility

(510,000)

(145,000)

(658,000)

Proceeds from unsecured senior notes

906,927

900,000

Payments on unsecured senior notes

(700,000)

Payments on secured mortgage loans

(97,361)

(241,021)

(77,024)

Deferred financing costs

(7,776)

(782)

(16,904)

Debt extinguishment costs

(18,383)

(1,909)

(10,571)

Security deposits

2,419

Proceeds from issuance of common stock

323,393

72,814

1,746,956

Issuance of OP Units

411

Repurchase and cancellation of common stock

(12,178)

(70,319)

(3,413)

Dividends paid

(256,117)

(252,651)

(207,087)

Distributions paid to noncontrolling interest of limited partners

(8,758)

(5,278)

(5,308)

Sale of noncontrolling interest

1,234

Net cash provided by (used in) financing activities

230,981

(498,735)

2,241,068

Net change in cash, cash equivalents and restricted cash

(95,914)

14,970

93,515

Cash, cash equivalents and restricted cash – beginning of year

133,530

118,560

25,045

Cash, cash equivalents and restricted cash – end of year

$

37,616

$

133,530

$

118,560

 

HEALTHCARE TRUST OF AMERICA, INC.

NOI, CASH NOI AND SAME-PROPERTY CASH NOI

(Unaudited and in thousands)

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Net income

$

9,036

$

15,605

$

30,758

$

217,626

General and administrative expenses

10,203

8,915

41,360

35,196

Transaction expenses

1,492

70

2,350

1,003

Depreciation and amortization expense

78,654

69,566

290,384

279,630

Impairment

8,887

Interest expense

24,031

24,457

96,632

101,849

Loss (gain) on sale of real estate, net

117

395

154

(165,977)

(Gain) loss on extinguishment of debt, net

(1,334)

21,646

(242)

Income from unconsolidated joint venture

(426)

(330)

(1,882)

(1,735)

Other income

(60)

(299)

(841)

(428)

NOI

$

123,047

$

117,045

$

480,561

$

475,809

NOI percentage growth

5.1

%

1.0

%

NOI

$

123,047

$

117,045

$

480,561

$

475,809

Straight-line rent adjustments, net

(1,600)

(2,394)

(9,861)

(10,683)

Amortization of (below) and above market leases/leasehold interests, net and other GAAP adjustments

(394)

26

(1,534)

99

Notes receivable interest income

(21)

(30)

(96)

(131)

Cash NOI

$

121,032

$

114,647

$

469,070

$

465,094

Acquisitions not owned/operated for all periods presented and disposed properties Cash NOI

(5,078)

(31)

(10,278)

(14,175)

Redevelopment Cash NOI

308

(1,281)

(2,653)

(6,457)

Intended for sale Cash NOI

(1,330)

(1,242)

(5,227)

(5,606)

Same-Property Cash NOI (1)

$

114,932

$

112,093

$

450,912

$

438,856

Same-Property Cash NOI percentage growth

2.5

%

2.7

%

(1) Same-Property includes 410 and 405 buildings for the three months and year ended December 31, 2019 and 2018, respectively.

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; (viii) income or loss from unconsolidated joint venture; and (ix) other income or expense.  HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties.  Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts («REITs»).  However, HTA’s use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of HTA’s financial performance.  NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments; (ii) amortization of below and above market leases/leasehold interests and other GAAP adjustments; and (iii) notes receivable interest income.  Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA’s revenue performance.  HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets.  Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs.  However, HTA’s use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned and operational properties referred to as «Same-Property».  Same-Property Cash NOI excludes (i) properties which have not been owned and operated by HTA during the entire span of all periods presented and disposed properties, (ii) HTA’s share of unconsolidated joint ventures, (iii) development, redevelopment and land parcels, (iv) properties intended for disposition in the near term which have (a) been approved by the Board of Directors, (b) are actively marketed for sale, and (c) an offer has been received at prices HTA would transact and the sales process is ongoing, and (v) certain non-routine items.  Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

FFO, NORMALIZED FFO AND NORMALIZED FAD

(Unaudited and in thousands, except per share data)

Three Months Ended December 31,

Year Ended December 31,

2019

2018

2019

2018

Net income attributable to common stockholders

$

8,918

$

15,329

$

30,154

$

213,463

Depreciation and amortization expense related to investments in real estate

77,758

69,001

287,572

277,446

Loss (gain) on sale of real estate, net

117

395

154

(165,977)

Impairment

8,887

Proportionate share of joint venture depreciation and amortization

468

469

1,858

1,746

FFO attributable to common stockholders

$

87,261

$

85,194

$

319,738

$

335,565

Transaction expenses

1,492

70

2,350

859

(Gain) loss on extinguishment of debt, net

(1,334)

21,646

(242)

Noncontrolling income from OP units included in diluted shares

118

252

538

4,074

Other normalizing items, net

144

Normalized FFO attributable to common stockholders

$

88,871

$

84,182

$

344,272

$

340,400

Non-cash compensation expense

2,299

1,925

10,127

9,755

Straight-line rent adjustments, net

(1,600)

(2,394)

(9,861)

(10,683)

Amortization of (below) and above market leases/leasehold interests and corporate assets, net

(580)

592

(535)

2,401

Deferred revenue – tenant improvement related and other

(1)

(300)

(5)

(499)

Amortization of deferred financing costs and debt discount/premium, net

935

1,403

5,216

5,260

Recurring capital expenditures, tenant improvements and leasing commissions

(17,663)

(17,117)

(59,803)

(61,375)

Normalized FAD attributable to common stockholders

$

72,261

$

68,291

$

289,411

$

285,259

Net income attributable to common stockholders per diluted share

$

0.04

$

0.07

$

0.14

$

1.02

FFO adjustments per diluted share, net

0.37

0.34

1.39

0.58

FFO attributable to common stockholders per diluted share

$

0.41

$

0.41

$

1.53

$

1.60

Normalized FFO adjustments per diluted share, net

0.01

(0.01)

0.11

0.02

Normalized FFO attributable to common stockholders per diluted share

$

0.42

$

0.40

$

1.64

$

1.62

Weighted average diluted common shares outstanding

211,472

210,338

209,605

210,061

HTA computes FFO in accordance with the current standards established by NAREIT.  NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures.  Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.

HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) noncontrolling income or loss from OP Units included in diluted shares; and (iv) other normalizing items, which include items that are unusual and infrequent in nature.  HTA’s methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs.

HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) non-cash compensation expense; (ii) straight-line rent adjustments; (iii) amortization of below and above market leases/leasehold interests and corporate assets; (iv) deferred revenue – tenant improvement related and other income; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions.  HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of its operating performance.  Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of its financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FAD should be reviewed in connection with other GAAP measurements.

HTA presents these non-GAAP financial measures because it considers them important supplemental measures of its operating performance and believes they are frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.  Historical cost accounting assumes that the value of real estate assets diminishes ratably over time.  Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  These non-GAAP financial measures should not be considered as alternatives to net income or loss attributable to common stockholders (computed in accordance with GAAP) as indicators of its financial performance.  FFO and Normalized FFO is not indicative of cash available to fund cash needs.  These non-GAAP financial measures should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

NET DEBT TO ADJUSTED EBITDAre

(Unaudited and in thousands)

Three Months Ended

December 31, 2019

Net income

$

9,036

Interest expense

24,031

Depreciation and amortization expense

78,654

Loss on sale of real estate, net

117

Proportionate share of joint venture depreciation and amortization

468

EBITDAre

$

112,306

Transaction expenses

1,492

Non-cash compensation expense

2,299

Pro forma impact of acquisitions/dispositions

3,909

Adjusted EBITDAre

$

120,006

Adjusted EBITDAre, annualized

$

480,024

As of December 31, 2019:

Debt

$

2,749,775

Less: cash and cash equivalents

32,713

Net Debt

$

2,717,062

Net Debt to Adjusted EBITDAre

5.7x

As defined by NAREIT, EBITDAre is computed as net income or loss (computed in accordance with GAAP) plus: (i) interest expense; (ii) income tax expense (not applicable to HTA); (iii) depreciation and amortization; (iv) impairment; (v) gain or loss on the sale of real estate; and (vi) the proportionate share of joint venture depreciation and amortization.

Adjusted EBITDAre is presented on an assumed annualized basis.  HTA defines Adjusted EBITDAre as EBITDAre (computed in accordance with NAREIT as defined above) plus: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) non-cash compensation expense; (iv) pro forma impact of its acquisitions/dispositions; and (v) other normalizing items.  HTA considers Adjusted EBITDAre an important measure because it provides additional information to allow management, investors, and its current and potential creditors to evaluate and compare its core operating results and its ability to service debt.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-2019-results-and-2020-earnings-guidance-301004899.html

SOURCE Healthcare Trust of America, Inc.